Psychological aspects of adductor spasmodic dysphonia: A prospective population controlled questionnaire study

Clinical Otolaryngology

Volumn 35, Issue 1, 2010, Pages 31-38

  Kaptein, A A ^a   Hughes, B M ^b   Scharloo, M ^a   Hondebrink, N ^a   Langeveld, T P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCTOR SPASMODIC DYSPHONIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EMOTION; FEMALE; HUMAN; MALE; MORBIDITY; OUTCOME ASSESSMENT; PERCEPTION; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SOCIAL PSYCHOLOGY; SPASMODIC DYSPHONIA; TERTIARY HEALTH CARE; VALIDITY;

COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DYSPHONIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 77449108544     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2009.02070.x     Document Type: Article

References (20)

1. Pearson E.J. Sapienza C.M. (2003) Historical approaches to the treatment of adductor-type spasmodic dysphonia (ADSD): review and tutorial. NeuroRehabilitation 18, 325 338
2. Leventhal H., Weinman J., Leventhal E.A. et al. (2008) Health psychology: the search for pathways between behavior and health. Annu. Rev. Psychol. 59, 477 505
3. Baylor C.R., Yorkston K.M., Eadie T.L. et al. (2007) The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences. J. Voice 21, 231 247
4. Paniello R.C., Barlow J. Serna J.S. (2008) Longitudinal follow-up of adductor spasmodic dysphonia patients after Botulinum injection: quality of life results. Laryngoscope 118, 564 568
5. Rubin A.D., Wodchis W.P., Spak C. et al. (2004) Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia. Arch. Otolaryngol. Head Neck Surg. 130, 415 420
6. Buck F., Drinnan M., Wilson J. et al. (2007) What are the illness perceptions of people with dysphonia: a pilot study. J. Laryngol. Otol. 121, 31 39
7. Kaptein A.A., Scharloo M., Helder D.I. et al. (2003) Representations of chronic illnesses. In The Self-regulation of Health and Illness Behavior, Cameron L. Leventhal H. (eds pp. 97 118. Routledge, London
8. Horne R., Weinman J. Hankins M. (1999) The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol. Health 14, 1 24
9. Halm E.A., Mora P. Leventhal H. (2006) No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 129, 573 580
10. Petrie K.J., Cameron L.D., Ellis C.J. et al. (2002) Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom. Med. 64, 580 586
11. Cohen J. (1992) A power primer. Psychol. Bull. 112, 155 159
12. Derogatis L.R. (1977) SCL-90: Administration, Scoring and Procedures Manual - I for the revised version. Baltimore, Johns Hopkins University School of Medicine, Clinical Psychometrics Research Unit, Baltimore
13. Broadbent E., Petrie K.J., Main J. et al. (2006) The Brief Illness Perception Questionnaire. J. Psychosom. Res. 60, 631 637
14. Hakkesteegt M.M., Wieringa M.H., Gerritsma E.J. et al. (2006) Reproducibility of the Dutch version of the Voice Handicap Index. Folia Phoniatr. Logoped. 58, 132 138
15. Aron A., Aron E.N. Coups E.J. (2005) Statistics for the Behavioral and Social Sciences, 3rd edn. Pearson, London
16. Hogikyan N.D., Wodchis W.P., Spak C. et al. (2001) Longitudinal effects of Botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with Aductory Spasmodic Dysphonia. J. Voice 15, 576 586
17. Watts C.C.W., Whurr R. Nye C. (2004) Botulinum toxin injections for the treatment of spasmodic dysphonia. Cochrane Database of Systematic Reviews Issue 3, CD004327
18. Cannito M.P., Kahane J.C. Chorna L. (2008) Vocal aging and adductor spasmodic dysphonia: response to Botulinum toxin injection. Clin. Intern. Aging 3, 131 151
19. Cannito M.P., Woodson G.E., Murry T. et al. (2004) Perceptual analyses of spasmodic dysphonia before and after treatment. Arch. Otolaryngol. Head Neck Surg. 130, 1393 1399
20. Kaptein A.A., van Korlaar I.M., Vossen C.Y. et al. (2007) Using the common-sense model to predict risk perception and disease related worry in individuals at risk for venous thrombosis. Health Psychol. 26, 807 812